Compliance with oral topotecan in patients with non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).

被引：0
|
作者：
Eckardt, J. R.
Ramlau, R.
Gervais, R.
Shepherd, F.
O'Brien, M.
Ciuleanu, T.
Dharan, B.
Wissel, P.
Ross, G.
机构：
[1] Ctr Canc Care & Res, St Louis, MO USA
[2] Reg Lung Dis Ctr, Poznan, Poland
[3] Ctr Francois Baclesse, F-14021 Caen, France
[4] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[5] Royal Marsden Hosp, Sutton, Surrey, England
[6] Oncol Inst Ion Chiricuta, Cluj Napoca, Romania
[7] GlaxoSmithKline Inc, Collegeville, PA USA
[8] GlaxoSmithKline Inc, Harlow, Essex, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：387S / 387S
页数：1
相关论文
共 50 条
  • [1] Transformation of Non-Small Cell Lung Cancer (NSCLC) to Small Cell Lung Cancer (SCLC), Mechanism of Treatment Resistance?
    Hamedi, Z.
    Kamboj, S.
    Kumar, S.
    Jiwani, R. A.
    Sharma, N.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [2] CHEMOTHERAPY FOR CEREBRAL METASTASES IN SMALL CELL LUNG-CANCER (SCLC) AND NON-SMALL CELL LUNG-CANCER (NSCLC)
    TWELVES, C
    SOUHAMI, R
    HARPER, P
    TOBIAS, J
    SPIRO, S
    GEDDES, D
    ASH, C
    DRAKE, J
    [J]. THORAX, 1988, 43 (10) : P841 - P841
  • [3] CEREBRAL METASTASES IN SMALL CELL LUNG-CANCER (SCLC) AND NON-SMALL CELL LUNG-CANCER (NSCLC) TREATED BY CHEMOTHERAPY
    TWELVES, C
    SOUHAMI, R
    HARPER, P
    TOBIAS, J
    SPIRO, S
    GEDDES, D
    ASH, C
    DRAKE, J
    [J]. BRITISH JOURNAL OF CANCER, 1989, 60 (03) : 461 - 461
  • [4] Pilot Study on the Tumor Immune Microenvironment Between Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC)
    Zhang, W.
    Yuan, X.
    Wang, X.
    Huang, S.
    Tu, J.
    Liu, F.
    Li, J.
    Li, J.
    Chen, Y.
    Chu, Q.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S132 - S132
  • [5] Topotecan in the treatment of non-small cell lung cancer
    Perez-Soler, R
    [J]. SEMINARS IN ONCOLOGY, 1997, 24 (06) : S34 - S41
  • [6] Systemic Therapy of Extensive Stage Small Cell Lung Cancer (SCLC): Contrasting Therapeutic Principles for SCLC and Non-small Cell Lung Cancer (NSCLC) in 2015
    Murray, Nevin
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S164 - S165
  • [7] Non-small cell lung cancer (NSCLC) in elderly patients
    Batura-Gabryel, H.
    Brajer, B.
    [J]. LUNG CANCER, 2006, 52 : S19 - S19
  • [8] Identification of signaling pathways active in small cell lung cancer (SCLC) compared to non-small cell lung cancer (NSCLC) by proteomic profiling
    Byers, Lauren Averett
    Wang, Jing
    Yordy, John
    Fan, You-Hong
    Giri, Uma
    Shen, Li
    Wistuba, Ignacio
    Girard, Luc
    Coombes, Kevin
    Weinstein, John
    Minna, John
    Heymach, John
    [J]. CANCER RESEARCH, 2010, 70
  • [9] Identification of signaling pathways active in small cell lung cancer (SCLC) compared to non-small cell lung cancer (NSCLC) by proteomic profiling
    Byers, Lauren Averett
    Wang, Jing
    Yordy, John
    Fan, You-Hong
    Girl, Uma
    Shen, Li
    Wistuba, Ignacio
    Girard, Luc
    Coombes, Kevin
    Weinstein, John
    Minna, John
    Heymach, John
    [J]. CANCER RESEARCH, 2010, 70
  • [10] Should we use small cell lung cancer (SCLC) or non-small cell lung cancer (NSCLC)-based therapy for the treatment of large cell neuroendocrine cancer (LCNEC) of the lung?
    Karim, Nagla Fawzy Abdel
    Namad, Tariq
    Ying, Jung
    Wang, Jiang
    Bhatt, Ananta
    Sakkal, Mohamed
    Morris, John Charles
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345